Stocks to buy

DraftKings (NASDAQ:DKNG) stock has a boring scoreboard this year. Year-to-date it’s barely up 4%, which is only a quarter of the S&P 500’s performance. However, this boring score does not reflect the excitement in DKNG stock. Source: Tada Images / Shutterstock.com It has had six rallies, each more than 30%. Two of them were compound

Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be

Dutch Bros (NYSE:BROS) went public on Sept. 14 at $23.00 per share and immediately spiked to $43.32 as of Sept. 30. That is a gain of more than 88.3% and has led some to argue that BROS stock is overvalued. Source: Alexander Oganezov / Shutterstock.com I looked at some of the numbers in the initial public

On Sept. 24, Carnival (NYSE:CCL) reported that voyages for its fiscal third quarter turned free cash flow (FCF) positive. Of course, this does not mean that the company is profitable yet. But Carnival is now clearly on track. As a result, things look very bright for CCL stock moving forward. Source: Ruth Peterkin / Shutterstock.com

The market has experienced increased volatility over the last few weeks. Investors are still nervous about COVID and inflation, plus new issues including the debt ceiling debate and a possibility of an Evergrande default in China. At times like these, investors may look to lower their risk profile.  One way to do that is to

In reviewing the opportunity in Roku (NASDAQ:ROKU) stock, I need to start with an apology. A few years ago, I harshly judged it for its delay in reaching profitability. I had good reason at the time, since after 16 years they were still losing money. Management has most definitely shut me up, though, and that’s

The coronavirus pandemic disrupted many businesses and was a boon to others. One sector that’s been riding high is the pharmaceutical industry. That’s especially true for companies that have brought a Covid-19 vaccine to market. Vaccine developer Novavax (NASDAQ:NVAX) is a perfect example. NVAX stock rose from relative obscurity with a share price of just

Cathie Wood just purchased a bunch of Peloton (NASDAQ:PTON) shares after PTON stock crumbled from $125 in late July to below $90 in late September. This stock is at the lowest level its been at since its recall issues earlier this year. And this is as low as it gets. Source: JHVEPhoto / Shutterstock.com As

Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in

Sofi Technologies (NASDAQ:SOFI) reported good Q2 results on Aug. 12, including record quarterly growth of 101% year-over-year (YoY) and adj. revenue up 74%. The problem is, as I wrote last month, SOFI stock looks to be fairly valued now. That seems to imply that the stock might not rise. Or could it? This article will

Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and

Opendoor (NASDAQ:OPEN), the digital platform for residential real estate, is still quite undervalued even though OPEN stock is up a good deal. As I predicted in my article back in July, the company’s massive buying spree — along with rising real estate market prices — has led to positive profits. Source: Shutterstock OPEN stock has actually

Production Preview Week 1 is on deck for Lucid Motors (NASDAQ:LCID), and people are taking notice. After all, this is a literal door-opening event, and LCID stock is up a few percent today alone. And there’s still more to come. Source: Around the World Photos / Shutterstock.com Long story short, Lucid Motors has long claimed

Nvidia (NASDAQ:NVDA) shares popped nearly 4% on Wednesday, helping NVDA stock recover from a three-day slide. With a Wednesday close of $219.41, NVDA is drawing closer to its Sept. 3 close of $228.43, its all-time high. So what’s the reason for the big move? Source: JHVEPhoto / Shutterstock.com Well, there were actually two reasons for

Editor’s Note: This article is part of Joanna’s Top Trades — a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week is Zoom (NASDAQ:ZM) as the top stock to trade this week. We all know video-calling software maker Zoom (NASDAQ:ZM). The pandemic high-flier capitalized on a stay-at-home workforce, growing

What an interesting week in the markets, huh? Things started off ugly. On Monday, stocks plunged. On Tuesday, they tried to bounce back, but failed. On Wednesday, they did bounce back – and the big gains kept flowing into the end of the week. Source: Shutterstock Source: Shutterstock Why all the volatility? The Fed. Long

On May 28, I wrote that Snowflake, the cloud-based data software platform company, had changed my mind. I forecast a higher value for SNOW stock. I projected that it would hit $300 based on my free cash flow (FCF) estimates and FCF yield metrics. Source: rblfmr / Shutterstock.com SNOW stock closed on Sept. 23 at

Addressing climate change has been a top priority since day one for the Biden administration. Their longer-term agenda being to halve the U.S. carbon footprint by 2030. This sent a lot of “clean-energy” stocks skyrocketing in the early part of the year. One is Clean Energy Fuels (NASDAQ:CLNE) stock. Source: ZikG / Shutterstock.com After trading

The Evergrande crisis seems like China’s Lehmann moment. The markets have been jittery and it remains to be seen if there is a larger spill-over. Amidst this concern, the markets continue to provide investing and speculative opportunities. If I had to focus on buying large-caps, I would look at low-beta stocks. These stocks would protect

Right now, you can say that Sundial Growers (NASDAQ:SNDL) is low-priced, but not cheap. In other words, shares are overvalued at 70 cents per share. Despite the fact the stock has fallen more than 82% off of its meme stock high set in February. Source: Postmodern Studio / Shutterstock.com The reason? Largely, the company’s heavily-dilutive